Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  JAMA Neurology

• Publication date

  2016-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/jamaneurol.2015.4265PMID 26751506PMCID PMC5469290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Weight Loss and Impact on Quality of Life in Parkinson’s Disease

  2015cited by this paper
• Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

  2015cited by this paper
• Risk of fracture in patients with Parkinson’s disease

  2013cited by this paper
• Design innovations and baseline findings in a long‐term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long‐Term Study–1

  2012cited by this paper
• The prevention and treatment of missing data in clinical trials.

  2012cited by this paper
• Body mass index in Parkinson's disease: a meta-analysis.

  2012cited by this paper
• 60 – Conduct of Stroke-Related Clinical Trials

  2011cited by this paper
• Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

  2011cited by this paper
• Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients

  2009cited by this paper
• Urate as a predictor of the rate of clinical decline in Parkinson disease.

  2009cited by this paper
• Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

  2008cited by this paper
• Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.

  2007cited by this paper
• Body mass index and risk of Parkinson's disease: a prospective cohort study.

  2007cited by this paper
• Advances in Group-Based Trajectory Modeling and an SAS Procedure for Estimating Them

  2007cited by this paper
• Body mass index and the risk of Parkinson´s disease

  2006cited by this paper
• Weight loss in Parkinson’s disease

  2006cited by this paper
• Body mass index and the risk of Parkinson disease

  2006cited by this paper
• Body weight in patients with Parkinson's disease

  2006cited by this paper
• Obesity and the risk of Parkinson's disease.

  2004cited by this paper
• Conduct of Stroke-Related Clinical Trials

  2004cited by this paper
• Weight loss in Parkinson's disease

  2003cited by this paper
• Risk factors for hip fracture among elderly patients with Parkinson's disease.

  2003cited by this paper
• Midlife adiposity and the future risk of Parkinson’s disease

  2002cited by this paper
• A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories

  2001cited by this paper
• Brain dopamine and obesity.

  2001cited by this paper
• Nutritional assessment and survival in ALS patients.

  2000cited by this paper
• Predictors of mortality in patients with Alzheimer’s disease living in nursing homes

  1999cited by this paper
• Stroke : pathophysiology, diagnosis, and management

  1998cited by this paper
• Free-living Daily Energy Expenditure in Patients with Parkinson's Disease

  1997cited by this paper
• Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.

  1996cited by this paper
• A study of the nutritional status of elderly patients with Parkinson's disease.

  1994cited by this paper
• Factors associated with slow progression in Huntington's disease.

  1991cited by this paper

• Factors associated with longitudinal MDS-UPDRS III score trajectories in early-stage Parkinson's disease.

  2026cites this paper
• Shaping Outcomes: Levodopa–Carbidopa Intestinal Gel Treatment and Nutrition in Parkinson’s Disease—A Prospective Observational Cohort Study

  2025cites this paper
• Association of waist circumference with all cause mortality in Parkinson’s disease

  2025cites this paper
• Metabolic dysregulation and resistance to high-fat diet-induced weight gain in mice overexpressing human wild-type α-synuclein

  2025cites this paper
• A 15-year bibliometric analysis of body mass index moderation in the management of Parkinson’s disease

  2025influential citation
• Body composition and resting metabolic rate in Parkinson's disease: A prospective cross-sectional single centre study.

  2025cites this paper
• Polygonatum cyrtonema polysaccharide alleviates dopaminergic neuron apoptosis in Parkinson's disease mouse model via inhibiting oxidative stress and endoplasmic reticulum stress.

  2025cites this paper
• The ketogenic diet and MetSyn in Parkinson’s disease – Symptoms, biomarkers, depression and anxiety: A case study

  2024cites this paper
• Peripheral immune profile in drug-naïve dementia with Lewy bodies

  2024cites this paper
• Genetic causal role of body mass index in multiple neurological diseases

  2024cites this paper
• The missing piece of the puzzle - The key role of the dietitian in the management of Parkinson's disease.

  2024cites this paper
• Impact of REM Sleep Behavior and Sleep Talking on Mortality in Parkinson's Disease

  2024cites this paper
• Body mass index in patients with Parkinson's disease: a meta-analysis.

  2024cites this paper
• Factors Affecting Malnutrition in Parkinson's Disease Patients Using Mini Nutritional Assessment at H. Adam Malik Hospital and Network Hospitals

  2024influential citation
• Peculiarities of head size, total and longitudinal body dimensions in Ukrainian men and women with multiple sclerosis

  2024cites this paper
• Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease

  2024cites this paper
• Resistance to high-fat diet-induced weight gain in transgenic mice overexpressing human wild-type α-synuclein: A model for metabolic dysfunction in Parkinson’s disease

  2024influential citation
• Association of body mass index with rapid eye movement sleep behavior disorder in Parkinson’s disease

  2024cites this paper
• Electroacupuncture blocked motor dysfunction and gut barrier damage by modulating intestinal NLRP3 inflammasome in MPTP-induced Parkinson's disease mice

  2024cites this paper
• Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression

  2023cites this paper
• Electroacupuncture alleviates motor dysfunction and gut barrier damage by modulating intestinal NLRP3 in�ammasome in MPTP-induced Parkinson's disease mice

  2023cites this paper
• Weight and survival after deep brain stimulation for Parkinson's disease.

  2023cites this paper
• Lifestyle modulators of neuroplasticity in Parkinson's disease: evidence in human neuroimaging studies.

  2023cites this paper
• The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysis

  2023cites this paper
• BMI decline patterns and relation to dementia risk across four decades of follow‐up in the Framingham Study

  2022cites this paper
• Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease

  2022cites this paper
• Initial BMI and Weight Loss Over Time Predict Mortality in Parkinson Disease.

  2022cites this paper
• Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches

  2022cites this paper
• Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease

  2022cites this paper
• Derivation and validation of a nomogram for predicting nonventilator hospital-acquired pneumonia among older hospitalized patients

  2022cites this paper
• Gastrointestinal Dysfunction in Parkinson’s Disease

  2022cites this paper
• Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies

  2022cites this paper
• Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment

  2022cites this paper
• Impact of Body Mass Index on the Age of Relapsing-Remitting Multiple Sclerosis Onset: A Retrospective Study

  2021cites this paper
• Weight loss and weight gain in Parkinson disease.

  2021cites this paper
• Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease

  2021cites this paper
• Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients

  2021cites this paper
• Associations of IL-1β and IL-6 gene polymorphisms with Parkinson's disease.

  2021cites this paper
• Changes in Body Composition Before and After Parkinson's Disease Diagnosis

  2021cites this paper
• Temporalis muscle thickness as an indicator of sarcopenia is associated with long-term motor outcomes in Parkinson's disease.

  2021cites this paper
• Тopical questions of nutrition in neurological practice

  2021cites this paper
• Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation.

  2021cites this paper
• Hypothalamic α-synuclein and its relation to autonomic symptoms and neuroendocrine abnormalities in Parkinson disease.

  2021cites this paper
• Non-motor symptoms in Parkinson's disease: Opening new avenues in treatment

  2021cites this paper
• The Impact of Dietary Intake and Physical Activity on Body Composition in Parkinson's Disease

  2021cites this paper
• Analyzing Head Pose in Remotely Collected Videos of People with Parkinson’s Disease

  2021cites this paper
• The Thermodynamic Consequences of Parkinson's Disease

  2021cites this paper
• Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson’s disease (the MEDI-PD study): study protocol for a randomised controlled trial

  2021cites this paper
• Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease

  2021cites this paper
• Subthalamic Nucleus Deep Brain Stimulation in a Patient with Severe Axial Symptoms and Suboptimal Levodopa Responsive Parkinson's Disease.

  2021cites this paper
• Prevalence and associated factors of malnutrition in patients with Parkinson's disease using CONUT and GNRI.

  2021cites this paper
• Mediterranean Diet Adherence in People With Parkinson's Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study

  2021cites this paper
• Effects of a structured dance program in Parkinson's disease. A Greek pilot study.

  2021cites this paper
• Prevalence, risk factors, and clinical correlations of underweight in Chinese newly diagnosed and drug-naïve patients with Parkinson’s disease

  2020cites this paper
• Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's Disease.

  2020cites this paper
• Parkinson’s disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia

  2020cites this paper
• Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment

  2020cites this paper
• Using Mendelian randomization to understand and develop treatments for neurodegenerative disease

  2020cites this paper
• Excessive apoptosis and ROS induced by ethionine affect neural cell viability and differentiation.

  2020cites this paper
• Sex differences in underweight and body mass index in Chinese early de novo patients with Parkinson's disease

  2020cites this paper
• A Mendelian randomization study of glycemic and anthropometric traits and Parkinson’s disease

  2020cites this paper
• Longitudinal association between dopamine agonists and weight in Parkinson's disease.

  2020cites this paper
• Dysphagia Affecting Quality of Life in Cerebellar Ataxia—a Large Survey

  2020cites this paper
• Gastrointestinal Care of the Parkinson Patient.

  2020cites this paper
• Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model

  2020cites this paper
• Mitochondrial Creatine Kinase is Decreased in the Serum of Idiopathic Parkinson’s Disease Patients

  2019cites this paper
• Untangling the relationship between fat distribution, nutritional status and Parkinson’s disease severity

  2019cites this paper
• Estimation of skeletal muscle mass in patients with spinocerebellar ataxia type 3 and 10

  2019cites this paper
• Differential leukocyte count is associated with clinical phenotype in Parkinson's disease.

  2019cites this paper
• Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.

  2019cites this paper
• Pathophysiological mechanisms of non-motor features and their role on the pathogenic process in Parkinson's disease

  2019cites this paper
• Uses for humanised mouse models in precision medicine for neurodegenerative disease

  2019cites this paper
• Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability?: a case–control study

  2019cites this paper
• Body mass index in patients with Multiple Sclerosis: a meta-analysis

  2019cites this paper
• Bilirubin-Related Differential Striatal [18F]FP-CIT Uptake in Parkinson Disease.

  2019cites this paper
• Prediction of future weight change with dopamine transporter in patients with Parkinson’s disease

  2019cites this paper
• Weight Loss in Parkinson’s Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth

  2018cites this paper
• Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects

  2018cites this paper
• Disease Specific Aspects of Malnutrition in Neurogeriatric Patients

  2018cites this paper
• Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease

  2018cites this paper
• Vitamin B12 and Parkinson's Disease: What is the Relationship?

  2018cites this paper
• Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease.

  2018cites this paper
• Vitamin B 12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson ’ s Disease

  2018cites this paper
• Prosthetic Status in Relation to Weight Status and Occupation among Parkinson's Disease Patients in Baghdad-Iraq

  2018cites this paper
• Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease

  2018cites this paper
• Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study

  2018cites this paper
• Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease.

  2018cites this paper
• Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort

  2017cites this paper
• Monogenic Diseases of DNA Repair

  2017cites this paper
• Weight in Parkinson's Disease: Phenotypical Significance.

  2017cites this paper
• Early weight loss in parkinsonism predicts poor outcomes

  2017cites this paper
• Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores

  2017cites this paper
• Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan

  2017cites this paper
• Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease

  2017cites this paper
• Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1

  2016cites this paper
• Neuroendocrine abnormalities in Parkinson's disease

  2016cites this paper
• Association Between Body Mass Index and Parkinson Disease.

  2016cites this paper
• Body fat distribution in Parkinson's disease: An MRI-based body fat quantification study.

  2016cites this paper
• Association Between Body Mass Index and Parkinson Disease-Reply.

  2016cites this paper